Pieris Pharmaceuticals Stock Alpha and Beta Analysis
| PIRS Stock | USD 15.93 0.08 0.50% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pieris Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pieris Pharmaceuticals over a specified time horizon. Remember, high Pieris Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pieris Pharmaceuticals' market risk premium analysis include:
Beta 0.45 | Alpha (0.23) | Risk 2.17 | Sharpe Ratio (0.09) | Expected Return (0.20) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pieris |
Pieris Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pieris Pharmaceuticals market risk premium is the additional return an investor will receive from holding Pieris Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pieris Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pieris Pharmaceuticals' performance over market.| α | -0.23 | β | 0.45 |
Pieris Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Pieris Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Pieris Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Pieris Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Pieris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pieris Pharmaceuticals shares will generate the highest return on investment. By understating and applying Pieris Pharmaceuticals stock market price indicators, traders can identify Pieris Pharmaceuticals position entry and exit signals to maximize returns.
Pieris Pharmaceuticals Return and Market Media
The median price of Pieris Pharmaceuticals for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 16.83 with a coefficient of variation of 4.1. The daily time series for the period is distributed with a sample standard deviation of 0.69, arithmetic mean of 16.81, and mean deviation of 0.54. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | PIRS Stock Alert Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders | 09/03/2024 |
2 | Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance Annual Conference | 10/15/2024 |
3 | Acquisition by Geraghty James A of tradable shares of Pieris Pharmaceuticals at 1.0 subject to Rule 16b-3 | 10/28/2024 |
4 | Insider Trading | 11/06/2024 |
5 | Pieris Pharmaceuticals Q3 Earnings Snapshot | 11/13/2024 |
6 | PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIR... | 11/20/2024 |
About Pieris Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pieris or other stocks. Alpha measures the amount that position in Pieris Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 38.49 | 81.87 | 4.88 | 4.63 | PTB Ratio | 4.81 | 2.76 | 0.61 | 0.58 |
Pieris Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Pieris Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pieris Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Pieris Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Pieris Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Pieris Pharmaceuticals' management manipulating its earnings.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Pieris Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Pieris Stock Analysis
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.